70 related articles for article (PubMed ID: 11858710)
1. Methods for preparation of recombinant cytokine proteins V. mutant analogues of human interferon-gamma with higher stability and activity.
Pechenov SE; Tikhonov RV; Shingarova LN; Korobko VG; Yakimov SA; Klyushnichenko VE; Babajantz AA; Beliaev DL; Kuznetzov VP; Shvetz VI; Wulfson AN
Protein Expr Purif; 2002 Mar; 24(2):173-80. PubMed ID: 11858710
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of recombinant cytokines. II. Effective method for isolation, purification and renaturation of human recombinant gamma-interferon].
Vul'fson AN; Tikhonov RV; Pechenov SE; Klyushnichenko VE; Miroshnikov AI
Bioorg Khim; 1997 Sep; 23(9):721-6. PubMed ID: 9441594
[TBL] [Abstract][Full Text] [Related]
3. Engineered acid-stabile human interferon gamma.
Kontsek P; Waschütza G; Kontseková E; Otto B
Cytokine; 2000 Jun; 12(6):708-10. PubMed ID: 10843749
[TBL] [Abstract][Full Text] [Related]
4. A rapid single-step purification method for human interferon-gamma from isolated Escherichia coli inclusion bodies.
Haelewyn J; De Ley M
Biochem Mol Biol Int; 1995 Dec; 37(6):1163-71. PubMed ID: 8747547
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cold-inducible RNA-binding protein increases interferon-gamma production in Chinese-hamster ovary cells.
Tan HK; Lee MM; Yap MG; Wang DI
Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):247-57. PubMed ID: 17608629
[TBL] [Abstract][Full Text] [Related]
6. Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type.
Slodowski O; Böhm J; Schöne B; Otto B
Eur J Biochem; 1991 Dec; 202(3):1133-40. PubMed ID: 1662603
[TBL] [Abstract][Full Text] [Related]
7. Thermal stability of human ferritin: concentration dependence and enhanced stability of an N-terminal fusion mutant.
Kim SW; Kim YH; Lee J
Biochem Biophys Res Commun; 2001 Nov; 289(1):125-9. PubMed ID: 11708788
[TBL] [Abstract][Full Text] [Related]
8. Effect of oxidative stress on the production of recombinant human interferon-gamma in Escherichia coli.
Mohammadian-Mosaabadi J; Naderi-Manesh H; Maghsoudi N; Khalilzadeh R; Shojaosadati SA; Ebrahimi M
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):37-42. PubMed ID: 15030320
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of hamster interferon-gamma is modulated by the carboxyl-terminal tail.
Zhao W; Valencia AZ; Melby PC
Cytokine; 2006 Jun; 34(5-6):243-51. PubMed ID: 16843003
[TBL] [Abstract][Full Text] [Related]
10. On-column refolding of recombinant human interferon-gamma inclusion bodies by expanded bed adsorption chromatography.
Jin T; Guan YX; Yao SJ; Lin DQ; Cho MG
Biotechnol Bioeng; 2006 Mar; 93(4):755-60. PubMed ID: 16261630
[TBL] [Abstract][Full Text] [Related]
11. On-column refolding of recombinant human interferon-gamma with an immobilized chaperone fragment.
Gao YG; Guan YX; Yao SJ; Cho MG
Biotechnol Prog; 2003; 19(3):915-20. PubMed ID: 12790657
[TBL] [Abstract][Full Text] [Related]
12. A single mutation at Tyr143 of human S-adenosylhomocysteine hydrolase renders the enzyme thermosensitive and affects the oxidation state of bound cofactor nicotinamide-adenine dinucleotide.
Beluzić R; Cuk M; Pavkov T; Fumić K; Barić I; Mudd SH; Jurak I; Vugrek O
Biochem J; 2006 Dec; 400(2):245-53. PubMed ID: 16872278
[TBL] [Abstract][Full Text] [Related]
13. Structure, stability, and chaperone function of alphaA-crystallin: role of N-terminal region.
Kundu M; Sen PC; Das KP
Biopolymers; 2007 Jun; 86(3):177-92. PubMed ID: 17345631
[TBL] [Abstract][Full Text] [Related]
14. A monomeric human apolipoprotein E carboxyl-terminal domain.
Fan D; Li Q; Korando L; Jerome WG; Wang J
Biochemistry; 2004 May; 43(17):5055-64. PubMed ID: 15109264
[TBL] [Abstract][Full Text] [Related]
15. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of E. coli Ribonuclease HI by the 'stability profile of mutant protein' (SPMP)-inspired random and non-random mutagenesis.
Haruki M; Saito Y; Ota M; Nishikawa K; Kanaya S
J Biotechnol; 2006 Jul; 124(3):512-22. PubMed ID: 16545882
[TBL] [Abstract][Full Text] [Related]
17. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and refolding in vitro of a recombinant human cyclophilin A mutant: effect of a single Pro/Ser substitution on cyclophilin A structure and properties.
Xu LR; Yan X; Luo M; Guan YX; Yao SJ
Biotechnol Prog; 2008; 24(2):302-10. PubMed ID: 18333624
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Forte LR; Volkert WA
Bioconjug Chem; 2004; 15(4):872-80. PubMed ID: 15264876
[TBL] [Abstract][Full Text] [Related]
20. Stability of recombinant bovine interferon-γ antiviral activity in the absence of stabilizing additives.
Xu Q; Nomura T; Ikeda M; Ohta M; Kameyama K; Konishi M; Wu D; Inumaru S; Murakami K
Microbiol Immunol; 2011 Aug; 55(8):595-8. PubMed ID: 21545512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
